We contribute to improving the prevention and treatment of diseases that threaten global health
The prevalence of cardiometabolic diseases has increased by more than 26% in the past 10 years
Today, more than 500 million people live with genetic and lifestyle-related cardiometabolic diseases such as diabetes, obesity and cardiovascular disease.
People do not have equal opportunities for a healthy life and treatment
Rising inequity in health is not just a problem for individuals but is also a great burden for families and society.
Every year about 1.3 million people die from multidrug-resistant infections
We urgently need to improve our international preparedness for effectively managing antimicrobial resistance and novel viruses.
Our grants
The Novo Nordisk Foundation awards grants based on applications in open competition and supports a large number of different areas within health, sustainability and life science.
Projects and initiatives we have supported
The Novo Nordisk Foundation Vaccine Accelerator (NVAC)
Enabling the NIVI mission by providing industry-level expertise in vaccine development
The Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI)
NIVI aims to develop new or improved vaccines for some of the deadliest respiratory diseases.
Lighthouse Consortium on Obesity Management (LightCOM)
Partnership for Education of health Professionals (PEP)
With the Partnership for Education of Health Professionals (PEP), the Novo Nordisk Foundation takes a step towards reducing inequity in health by strengthening the education of health professionals in India, Kenya and eastern Africa.
Danish Pioneer Centre for Artificial Intelligence
Artificial intelligence will contribute to solving big societal challenges
PIG-PARADIGM – research into the intestinal resilience of piglets
The Novo Nordisk Foundation has awarded DKK 150 million (€20.1 million) for an interdisciplinary research project that may lead to a reduction in the use of antibiotics in the pig farming industry.
AMR Action Fund – global initiative to combat antimicrobial resistance
Several leading pharmaceutical companies and foundations have raised USD 1 billion to launch the AMR Action Fund. The aim is to bring 2–4 new antibiotics to patients by 2030.
Novo Nordisk Foundation Center for Genomic Mechanisms of Disease
With a USD 47.5 million commitment over a five-year period, the Foundation has supported the establishment of a new centre for genomic research at the Broad Institute of MIT and Harvard in Boston (US).
Would you like to read more about the Novo Nordisk Foundation's 2030 strategy?
Towards 2030, we will increase our efforts towards solving urgent and global societal challenges. We have three focus areas.Impact
We continually measure the societal effect of our projects and initiatives.Health-related news
NIVI welcomes Executive Director and CEO to lead novel vaccine research and development initiative
Prize for excellence awarded to paediatric endocrinologist for groundbreaking research into the origin and consequences of childhood obesity
